Cargando…
Ascertaining Medication Use and Patient-Reported Outcomes via an App and Exploring Gamification in Patients With Multiple Sclerosis Treated With Interferon β-1b: Observational Study
BACKGROUND: The BETACONNECT autoinjector and myBETAapp app were designed to support patients with multiple sclerosis receiving interferon β-1b and are an ideal platform for digital observational studies. A recent pilot study in Germany demonstrated the feasibility of using the app to recruit patient...
Autores principales: | Limmroth, Volker, Bayer-Gersmann, Kirsten, Mueller, Christian, Schürks, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929528/ https://www.ncbi.nlm.nih.gov/pubmed/35285806 http://dx.doi.org/10.2196/31972 |
Ejemplares similares
-
Correction: Ascertaining Medication Use and Patient-Reported Outcomes via an App and Exploring Gamification in Patients With Multiple Sclerosis Treated With Interferon β-1b: Observational Study
por: Limmroth, Volker, et al.
Publicado: (2022) -
Assessment of Medication Adherence Using a Medical App Among Patients With Multiple Sclerosis Treated With Interferon Beta-1b: Pilot Digital Observational Study (PROmyBETAapp)
por: Limmroth, Volker, et al.
Publicado: (2019) -
Predictors of Adherence Among Patients With Multiple Sclerosis Using the BETACONNECT(®) Autoinjector: A Prospective Observational Cohort Study
por: Köhler, Wolfgang, et al.
Publicado: (2021) -
Evaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort study
por: Zettl, Uwe K, et al.
Publicado: (2013) -
Sleep quality, daytime sleepiness, fatigue, and quality of life in patients with multiple sclerosis treated with interferon beta-1b: results from a prospective observational cohort study
por: Kotterba, Sylvia, et al.
Publicado: (2018)